179 related articles for article (PubMed ID: 9787982)
1. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children.
Sabbah A; Marzetto M
Curr Med Res Opin; 1998; 14(3):161-70. PubMed ID: 9787982
[TBL] [Abstract][Full Text] [Related]
2. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
[TBL] [Abstract][Full Text] [Related]
3. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study.
Giede-Tuch C; Westhoff M; Zarth A
Allergy; 1998 Sep; 53(9):857-62. PubMed ID: 9788686
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis.
Lenhard G; Mivsek-Music E; Perrin-Fayolle M; Obtulowicz K; Secchi A
Curr Med Res Opin; 1997; 14(1):21-8. PubMed ID: 9524790
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis.
James IG; Campbell LM; Harrison JM; Fell PJ; Ellers-Lenz B; Petzold U
Curr Med Res Opin; 2003; 19(4):313-20. PubMed ID: 12841924
[TBL] [Abstract][Full Text] [Related]
6. Topical azelastine in perennial allergic conjunctivitis.
Canonica GW; Ciprandi G; Petzold U; Kolb C; Ellers-Lenz B; Hermann R
Curr Med Res Opin; 2003; 19(4):321-9. PubMed ID: 12841925
[TBL] [Abstract][Full Text] [Related]
7. Azelastine eye drops in the treatment of perennial allergic conjunctivitis.
Nazarov O; Petzold U; Haase H; Nguyen DT; Ellers-Lenz B; Hermann R
Arzneimittelforschung; 2003; 53(3):167-73. PubMed ID: 12705171
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
Falser N; Wober W; Rahlfs VW; Baehre M
Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
[TBL] [Abstract][Full Text] [Related]
10. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
Vermeulen J; Mercer M
Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
[TBL] [Abstract][Full Text] [Related]
13. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
[TBL] [Abstract][Full Text] [Related]
14. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study.
Duarte C; Baëhre M; Gharakhanian S; Leynadier F;
J Investig Allergol Clin Immunol; 2001; 11(1):34-40. PubMed ID: 11436969
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B
Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880
[TBL] [Abstract][Full Text] [Related]
17. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
Noble S; McTavish D
Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.
Whitcup SM; Bradford R; Lue J; Schiffman RM; Abelson MB
Clin Ther; 2004 Jan; 26(1):29-34. PubMed ID: 14996515
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.
Spangler DL; Bensch G; Berdy GJ
Clin Ther; 2001 Aug; 23(8):1272-80. PubMed ID: 11558863
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of topical levocabastine compared with oral terfenadine.
Bahmer FA; Ruprecht KW
Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
